The first and only oral GLP-1 for weight loss in adults is now available to consumers.
The US Food and Drug Administration on Monday approved a daily pill version of Novo Nordisk's weight-loss drug Wegovy, introducing a new option for how patients can take medicines in a class of drugs that has revolutionized obesity treatment.
The new implants will be for weight loss in cats and dogs
The cash price for popular weight-loss medication Wegovy is dropping by 30% in the U.S. on Monday, according to Novo Nordisk.
The Trump administration announced deals on Thursday with pharmaceutical giants Novo Nordisk and Eli Lilly that would lower the cost of GLP-1 drugs for many Americans.